MarketCap
Facebook
X
Telegram
AVITA Medical Balance Sheet 2025-2011 | RCEL
Brief overview of AVITA Medical's balance sheet structure
The balance sheet is assessed across five available annual reports spanning 2021 to 2025.
Assets finished at $56.4 million versus $116 million initially, losing -51.4%. The balance sheet contracted.
Asset growth of -51.4% came with a +541.2% rise in liabilities. Financial leverage became more prominent.
Negative shareholders' equity signals an accumulated net asset deficit and calls for particular caution.
The cash reserve occupies 18.2% of the balance sheet, previously 47.8%. It is one marker of short-term resilience.
The accumulated result is -$408.4 million and remains below zero. The number alone does not explain whether losses, dividends or repurchases were the main cause.
Balance sheet takeaway
AVITA Medical's balance sheet profile remains vulnerable. Lower liabilities and capital accumulation are the main routes to improvement.
Annual Balance Sheet AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | 29.1 M | 18.6 M | -17.2 M | -53.9 M | -71.7 M | -20.3 M | -10.8 M | -2.91 M | -3.12 M | -190 K | -3.43 M | -9.69 M | -8.42 M | -13.5 M |
Long Term Debt |
- | 42.2 M | 39.8 M | 306 K | 918 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
929 K | 900 K | 895 K | 612 K | 720 K | 533 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 2.35 M | 466 K | 98.7 K | - | - | - | - | - | - | - |
Total Current Liabilities |
62.7 M | 20.2 M | 13.2 M | 10.7 M | 9.15 M | 7.71 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
73 M | 75 M | 61.9 M | 13 M | 11.4 M | 10.1 M | 4.87 M | 2.95 M | 1.96 M | 1.31 M | 941 K | 1.68 M | 2.24 M | 2.2 M | 1.54 M |
Retained Earnings |
-408 M | -360 M | -298 M | -263 M | -236 M | -195 M | -129 M | -109 M | -102 M | -90.4 M | -87 M | -100 M | -94.9 M | -98.9 M | -95.2 M |
Total Assets |
56.4 M | 79.7 M | 112 M | 98.3 M | 116 M | 82.5 M | 25.7 M | 16.9 M | 5.89 M | 6.42 M | 4.17 M | 6.89 M | 11.8 M | 11 M | 18.7 M |
Cash and Cash Equivalents |
10.2 M | 14 M | 22.1 M | 18.2 M | 55.5 M | 73.6 M | 20.4 M | 11 M | - | - | - | - | - | - | - |
Book Value |
-16.6 M | 4.74 M | 49.7 M | 85.3 M | 105 M | 72.4 M | 20.9 M | 14 M | 3.94 M | 5.12 M | 3.23 M | 5.2 M | 9.54 M | 8.75 M | 17.2 M |
Total Shareholders Equity |
-16.6 M | 4.5 M | 49.1 M | 84.7 M | 105 M | 72.4 M | 20.8 M | 14 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet AVITA Medical
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.82 M | 1.98 M | - | 42.2 M | 41.5 M | 42.2 M | 42.5 M | 41 M | 41.3 M | 39.8 M | 1.84 M | 1.05 M | 1.24 M | 306 K | 405 K | 532 K | 726 K | 918 K | 1.11 M | 878 K | 878 K | 1.24 M | 1.78 M | 1.92 M | 1.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
75.6 M | 74.7 M | 70.4 M | 71 M | 74.1 M | 75 M | 68.6 M | 63.5 M | 64 M | 61.9 M | 17.4 M | 16.5 M | 14.3 M | 13 M | 11.7 M | 9.95 M | 8.68 M | 11.4 M | 9.68 M | 9.85 M | 9.85 M | 9.71 M | 9.93 M | 10.1 M | 10.1 M | - | - | 4.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | 205 K | - | 33 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-427 M | -419 M | -397 M | -384 M | -374 M | -360 M | -348 M | -332 M | -317 M | -298 M | -291 M | -282 M | -272 M | -263 M | -257 M | -252 M | -245 M | -236 M | -227 M | -221 M | -221 M | -211 M | -205 M | -195 M | -195 M | - | - | -153 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
47.8 M | 51.5 M | 63.7 M | 58.1 M | 69.6 M | 79.7 M | 81.1 M | 87.8 M | 97.4 M | 112 M | 81 M | 86.3 M | 92.6 M | 98.3 M | 99.9 M | 103 M | 106 M | 116 M | 121 M | 126 M | 126 M | 69.3 M | 75.4 M | 82.5 M | 82.5 M | - | - | 25.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
9.14 M | 8.31 M | 15.4 M | 12.2 M | 14.9 M | 14 M | 40.9 M | 17.5 M | 20.9 M | 22.1 M | 50.9 M | 37.5 M | 28 M | 18.2 M | 23.8 M | 34.9 M | 23.7 M | 55.5 M | 60.7 M | 111 M | 111 M | 59.8 M | 65.8 M | 73.6 M | 73.6 M | 87.5 M | 15.3 M | 20.2 M | - | - | - | 11 M | - | - | - | 2.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-27.8 M | -23.2 M | -6.67 M | -12.8 M | -4.51 M | 4.74 M | 12.5 M | 24.3 M | 33.4 M | 49.7 M | 63.6 M | 69.9 M | 78.4 M | 85.3 M | 88.3 M | 92.7 M | 97.8 M | 105 M | 111 M | 116 M | 116 M | 59.6 M | 65.5 M | 72.4 M | 72.4 M | - | - | 20.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-27.8 M | -23.2 M | -6.67 M | -12.9 M | -4.57 M | 4.5 M | 12.2 M | 23.9 M | 32.6 M | 49.1 M | 63 M | 68.6 M | 77.6 M | 84.7 M | 88 M | 92.6 M | 97.8 M | 105 M | 111 M | 116 M | 116 M | 59.6 M | 59.6 M | 59.6 M | 65.5 M | 87.3 M | 18 M | 20.8 M | - | - | - | 14 M | - | - | - | 3.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of AVITA Medical, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
France
China
Israel
Canada
Britain